AJMC November 29, 2024
Key Takeaways
- The Medicare CBP reduced spending on durable medical equipment but did not significantly affect oxygen use or clinical outcomes in COPD patients.
- New oxygen prescriptions decreased by 22.8%, while discontinuations increased by 11.8% among Medicare beneficiaries with COPD.
- No differential changes were observed in clinical outcomes, such as mortality or hospitalizations, due to CBP implementation.
- The study suggests further research is needed to evaluate CBP’s impact on other chronic lung diseases and explore other factors affecting oxygen prescribing trends.
While the Medicare Competitive Bidding Program reduced spending, it did not significantly impact supplemental oxygen use or clinical outcomes among patients with chronic obstructive pulmonary disease (COPD).
While the Medicare Competitive Bidding Program (CBP) was associated with...